Page 95 - Read Online
P. 95

Page 12 of 16                                      Mataix et al. Plast Aesthet Res 2020;7:69  I  http://dx.doi.org/10.20517/2347-9264.2020.138

                                                                  ®
               Table 1. Summary of studies supporting a protective role for Edafence  against exposome agents
                         Exposome agent  Experimental model  EDA Concentrations  Phenotypes improved by EDA  Ref.
                In vitro  H 2 O 2 /oxidative stress  in vitro   0.3-1 mg/mL  *Viability              [78]
                                          (HF)                            *Senescence (β-galactosidase, Sirt1,
                                                                          LmnC)
                                                                          *Proliferation [cytometry, proliferating
                                                                          cell nuclear antigen (PCNA)]
                                                                          *Antioxidant response (Trx2)
                      Osmotic stress      in vitro       0.3-1 mg/mL      *Viability                 [75]
                                          (HF)
                      Thermal stress      in vitro       2.5 mg/mL        *Viability                 [75]
                      (heat and cold)     (HaCaT)                         *Mitochondrial potential and corrected
                                                                          mitochondrial potential
                      Natural aging       in vitro       0.9 mg/mL        *Telomere length           [84]
                                          (Keratinocytes)
                      Tobacco (5%)        in vitro       5-10 mg/mL       *Viability                 [81]
                      Urban pollution:    (HF)                            *Cell morphology
                      Cr (III y VI) 6 mcg;
                      Cd 3 mcg y As 9 mmol/L
                      Urban pollution:    in vitro       0.1-0.3 mg/mL    *Viability & cell morphology   [79]
                      Dioxin (TCDD, 10 nmol/L)/  (HF, HaCaT)              *DDR (γH2AX, PARP)
                                   2
                      UVA (3000 mJ/cm ) &                                 *Stress/apoptotic signaling (caspase
                                      2
                      UVB (300 y 700 mJ/cm )                              3, survivin, autophagy (LC3B), AhR)
                                                                          *Tissue remodeling (MMP1, loricrin)
                      Dioxins 10 nmol/L   Human Skin organ   2.5 mg/mL    *Tissue architecture and integrity   [80]
                      Urban pollution     Culture                         *Viability
                      (As 9 mmol/L, Cr VI 0.5                             *Apoptosis
                      mmol/L)
                      Visible light       in vitro       0.1-0.5 mg/mL    *Viability & cell morphology   [82]
                      (400-730 nm)        (HF, HaCaT)                     *DDR (γH2AX, PARP)
                      Infrared                                            *Stress/apoptotic signaling
                      (550-1400 nm)                                       [caspase-3, survivin, autophagy
                                                                          (LC3B), AhR]
                                                                          *Tissue remodeling (MMP1, loricrin,
                                                                          collagen I, elastin)
                      Blue light          in vitro       0.1 mg/mL        *Viability                 [83]
                                          (HF, Melanocytes)               *ROS levels
                                                                          *Mitochondrial integrity (architecture
                                                                          and membrane potential)
                                                                          *Melanization
                In vivo  Facial Photoaging               Commercial compound   *Viscoelasticity & firmness   [89]
                                                                 ®
                                                                                  ®
                      (age 45-65 year)                   (EDAFENCE ,      (Cutometer )
                                                                                             ®
                                                                                     ®
                                                         RetinSphere,     *Wrinkles (Visia  & Visioline )
                                                         Niacinamide)
                      Urban pollution                    Commercial compound   *Barrier function (TEWL)    [87]
                                                                     ®
                      (In winter; age 35-45 year)        (EDAFENCE , SCA ,   *Antioxidant effect (SQOOH/SQ)
                                                                 ®
                                                                                               ®
                                                         vitamin C, ferulic acid)  *Remove dark spot (Colorimeter )
                      Urban pollution                    Commercial compound   *Barrier function     [88]
                                                                 ®
                                                                     ®
                      (In summer; age 35-45              (EDAFENCE , SCA ,   (TEWL & Corneometry)
                      year)                              vitamin C, ferulic acid)  *Antioxidant effect (SQOOH/SQ)
               DDR: DNA damage response; γH2AX: phosphorylated H2A histone family member X; PARP: poly-ADP ribose polymerase; TEWL:
               transepidermal water loss
               activity and, most importantly, on the translation of those promising in vitro and ex vivo findings to the
               effects attainable in vivo.
               DECLARATIONS
               Acknowledgments
               Miguel Sánchez-Álvarez provided support for manuscript preparation and editing.


               Authors’ contributions
               Substantially contributed to the conception and design of the review: Pérez-Davó A
               Organized and performed meta-analysis across in vivo and in vitro Edafence® studies: Mataix M,
   90   91   92   93   94   95   96   97   98   99   100